We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Axis-Shield | LSE:ASD | London | Ordinary Share | GB0008039975 | ORD 35P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 469.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMASD
RNS Number : 2124R
Axis-Shield PLC
01 November 2011
AXIS-SHIELD PLC
AXIS-SHIELD PARTNERS WITH LARGEST U.S. RETAIL MEDICAL CLINIC TO PROVIDE AFINION(TM) SYSTEMS FOR DIABETES MANAGEMENT
CVS Caremark's MinuteClinic selects Afinion(TM) for haemoglobin A1c testing
Dundee, Scotland, 1 November 2011. Axis-Shield plc (LSE:ASD, OSE:ASD) ("Axis-Shield" or the "Company"), the international and innovative in vitro diagnostics company, today announces that it has signed a new agreement with MinuteClinic, the largest retail medical clinic provider in the United States. Under the terms of the agreement, Axis-Shield will provide an Afinion(TM) analyser for each of the approximately 600 MinuteClinic locations in the U.S. so patients can access haemoglobin A1c testing, with results provided in three minutes.
MinuteClinic is a division of CVS Caremark, the largest pharmacy health care provider in the United States. MinuteClinic's walk-in medical clinics are staffed by nurse practitioners and physician assistants, who provide treatment for common family illnesses and injuries, administer vaccinations, conduct physicals and wellness screenings, and offer monitoring for chronic conditions such as diabetes, high cholesterol, high blood pressure and asthma.
Ian Gilham, Chief Executive Officer of Axis-Shield, commented: "We are pleased to be partnering with the largest provider of walk-in medical clinics to bring the simplicity and reliability of Afinion(TM) directly to patients, enabling widespread access to routine haemoglobin A1c testing."
-Ends-
For further enquiries, please contact:
Axis-Shield plc Ian Gilham, Chief Executive Officer Tel: +44 203 178 7849 Ronny Hermansen, Finance Director M:Communications Peter Laing / Emma Thompson / Tel: +44 207 920 2330 Claire Dickinson E-mail: axisshield@mcomgroup.com Corporate Communications (Norway) Geir Bjorlo / Hakon Ronning Tel: +47 23 89 89 30
Notes for Editors
About Axis-Shield
Headquartered in Dundee with R&D and manufacturing facilities in Dundee and Oslo, Axis-Shield is a leading international and innovative company operating in faster growing segments of the in vitro diagnostics (IVD) market. Axis-Shield provides point-of-care testing via its Afinion(TM) and NycoCard(R) instruments and also serves the clinical laboratory through the development of novel tests, particularly for the high throughput analysers of blue-chip original equipment manufacturers (OEMs). The Company has a strong franchise in the diabetes testing market and is developing a cholesterol/lipid panel for testing at the point-of-care, both major areas for future growth. Through its Direct Distribution division, Axis-Shield also markets its own and other third-party products including medical devices to end users in key markets including the USA, Germany, Switzerland, the UK and the Nordic region. For more information on Axis-Shield, please refer to www.axis-shield.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFDFEFFFFSEES
1 Year Axis-shield Chart |
1 Month Axis-shield Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions